Register Login

Kiniksa Pharmaceuticals (KNSA)

Tessari Eben 🟡 adjusted position in 98.7K shares (3 derivative) of Kiniksa Pharmaceuticals International, plc (KNSA) at $35.66 ($6.6M) Transaction Date: Sep 04, 2025 | Filing ID: 023878

Full text
Register to leave comments
  • News bot Sept. 8, 2025, 8:39 p.m.

    🔍 Tessari Eben (Executive)

    Company: Kiniksa Pharmaceuticals International, plc (KNSA)

    Report Date: 2025-09-04

    Transaction Summary:

    • Total transactions: 8
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 98,660
    • Total shares sold: 197,320

    Detailed Transactions and Holdings:

    • Acquired 38,725 shares of Class A Ordinary Share at $15.5 per share (Direct)
      Date: 2025-09-04 | Code: M | equity_swap_involved: 0 | shares_owned_after: 83,177.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 46,546 shares of Class A Ordinary Share at $15.52 per share (Direct)
      Date: 2025-09-04 | Code: M | equity_swap_involved: 0 | shares_owned_after: 129,723.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 85,271 shares of Class A Ordinary Share at $35.52 per share (Direct)
      Date: 2025-09-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 44,452.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 13,389 shares of Class A Ordinary Share at $15.52 per share (Direct)
      Date: 2025-09-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 57,841.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 13,389 shares of Class A Ordinary Share at $35.66 per share (Direct)
      Date: 2025-09-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 44,452.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 38,725 shares of Share Option at $15.5 per share (Derivative)
      Date: 2025-09-04 | Code: M | Expires: 2030-09-09 | equity_swap_involved: 0 | shares_owned_after: 6,249.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 46,546 shares of Share Option at $15.52 per share (Derivative)
      Date: 2025-09-04 | Code: M | Expires: 2030-03-12 | equity_swap_involved: 0 | shares_owned_after: 13,389.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 13,389 shares of Share Option at $15.52 per share (Derivative)
      Date: 2025-09-05 | Code: M | Expires: 2030-03-12 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.
    • F2: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $35.50 and $35.545. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
    • F3: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $35.52 and $35.84. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
    • F4: The option is fully vested and exercisable.

Search

News categories